Barclays Maintains Overweight on Humana, Raises Price Target to $587
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice TargetHot
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Barclays analyst Andrew Mok maintains Humana (NYSE:HUM) with a Overweight and raises the price target from $582 to $587.
Barclays analyst Andrew Mok maintains Humana (NYSE:HUM) with a Overweight and raises the price target from $582 to $587.
More on HUM
Analyst ratings Benzinga
TD Cowen Upgrades Humana to Buy, Raises Price Target to $485TD Cowen analyst Ryan Langston upgrades Humana (NYSE:HUM) from Hold to Buy and raises the price target from $430 to $485.
